Flovent®

INHALED CORTICOSTEROIDS

INHALED CORTICOSTEROID (ICS)

  • Class

    • Inhaled corticosteroid (ICS)

  • Active ingredient

    • Fluticasone propionate

  • Device

  • Age

    • 4 +
  • Typical use

    • Asthma
      Initial controller

    Asthma management principles
    • COPD (off-label)
      in addition to a dual bronchodilation (LAMA/LABA) when exacerbating

    COPD management principles
  • Marketed strength

    • 100 mcg
    • 250 mcg
    • 500 mcg
  • Number of doses

    • 60 doses
  • Dose indicator

    • Yes | Numerical
  • Usual adult dosage

    • Low | 100 mcg – 1 inh BID
      Medium | 250 mcg – 1 inh BID
      High | 500 mcg – 1 inh BID
      Maximum daily dose: 2000 mcg

    ICS dosing
  • Usual pediatric dosage

    • 4-5 years 
      Not recommended

       

      6-11 years
      Low
      | 100 mcg – 1 inh BID
      Medium | 250 mcg – 1 inh QD

      12-17 years
      See adult dosage

    ICS dosing
  • Required inspiratory flow

    • > 30 - 60 L/min 
      Medium-low internal resistance (R2)

    Inspiratory flows
  • Public coverage

    • 100 mcg | all provinces except AB - MN | Open/Regular Benefit
      100 mcg | AB - MN | Not a benefit 
      250 mcg and 500 mcg  | all provinces | Open/Regular Benefit

  • Advantages

    • Precise dose counter
  • Disadvantages

    • BID dosing
    Side effects

Product monograph

Dowanload

Search for other inhalers